• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

节段性支气管激发在变应性哮喘中的安全性和细胞反应。

Safety of and cellular response to segmental bronchoprovocation in allergic asthma.

机构信息

Allergy, Pulmonary and Critical Care Division, Department of Medicine, University of Wisconsin, Madison, WI, USA.

出版信息

PLoS One. 2013;8(1):e51963. doi: 10.1371/journal.pone.0051963. Epub 2013 Jan 16.

DOI:10.1371/journal.pone.0051963
PMID:23341886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3547018/
Abstract

RATIONALE

Despite its incorporation into research studies, the safety aspects of segmental allergen bronchoprovocation and differences in cellular response among different allergens have received limited consideration.

METHODS

We performed 87 segmental challenges in 77 allergic asthma subjects. Allergen dose was based on each subject's response to whole lung allergen challenge. Bronchoalveolar lavage was performed at 0 and 48 hours. Safety indicators included spirometry, oxygen saturation, heart rate, and symptoms.

RESULTS

Among subjects challenged with ragweed, cat dander, or house dust mite, there were no differences in safety indicators. Subjects demonstrated a modest oxygen desaturation and tachycardia during the procedure that returned to normal prior to discharge. We observed a modest reduction in forced vital capacity and forced expiratory volume in one second following bronchoscopy. The most common symptoms following the procedure were cough, sore throat and fatigue. Total bronchoalveolar lavage fluid cell numbers increased from 13±4 to 106±108×10(4) per milliliter and eosinophils increased from 1±2 to 44±20 percent, with no significant differences among the three allergens.

CONCLUSIONS

In mild allergic asthma, segmental allergen bronchoprovocation, using individualized doses of aeroallergens, was safe and yielded similar cellular responses.

摘要

原理

尽管分段过敏原支气管激发已被纳入研究,但对其安全性方面以及不同过敏原之间细胞反应的差异关注有限。

方法

我们对 77 名过敏性哮喘患者进行了 87 次分段挑战。过敏原剂量基于每个患者对全肺过敏原激发的反应。支气管肺泡灌洗在 0 小时和 48 小时进行。安全性指标包括肺活量、血氧饱和度、心率和症状。

结果

在接受豚草、猫皮屑或屋尘螨挑战的患者中,安全性指标无差异。患者在该过程中表现出适度的氧饱和度下降和心动过速,但在出院前恢复正常。我们观察到支气管镜检查后用力肺活量和一秒用力呼气量略有下降。该过程后最常见的症状是咳嗽、喉咙痛和疲劳。总支气管肺泡灌洗液细胞数从 13±4 增加到 106±108×10(4)个/毫升,嗜酸性粒细胞从 1±2 增加到 44±20%,三种过敏原之间无显著差异。

结论

在轻度过敏性哮喘中,使用个体化的气传过敏原剂量进行分段过敏原支气管激发是安全的,且产生相似的细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/46d8c9a5d0d8/pone.0051963.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/12cbb6db1e58/pone.0051963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/5d1b03365178/pone.0051963.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/28aa990277ad/pone.0051963.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/46d8c9a5d0d8/pone.0051963.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/12cbb6db1e58/pone.0051963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/5d1b03365178/pone.0051963.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/28aa990277ad/pone.0051963.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f23/3547018/46d8c9a5d0d8/pone.0051963.g004.jpg

相似文献

1
Safety of and cellular response to segmental bronchoprovocation in allergic asthma.节段性支气管激发在变应性哮喘中的安全性和细胞反应。
PLoS One. 2013;8(1):e51963. doi: 10.1371/journal.pone.0051963. Epub 2013 Jan 16.
2
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma.哮喘患者对节段性支气管肺激发试验的即刻和迟发性过敏反应。
Am J Respir Crit Care Med. 1997 May;155(5):1515-21. doi: 10.1164/ajrccm.155.5.9154851.
3
Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma.屋尘螨过敏患者(无论有无哮喘)中变应原诱导的支气管炎症。
Clin Exp Allergy. 2002 Dec;32(12):1720-7. doi: 10.1046/j.1365-2222.2002.01542.x.
4
Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation.患有轻度和中度哮喘的受试者对节段性变应原激发的反应是相似的、可重复的、变应原特异性炎症。
J Allergy Clin Immunol. 2001 Dec;108(6):908-14. doi: 10.1067/mai.2001.119413.
5
Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite.用屋尘螨局部激发致敏绵羊后,诱导其肺部发生变应性炎症。
Clin Exp Allergy. 2003 Mar;33(3):367-75. doi: 10.1046/j.1365-2222.2003.01534.x.
6
Quantification of pulmonary inflammation after segmental allergen challenge using turbo-inversion recovery-magnitude magnetic resonance imaging.使用涡轮反转恢复-幅度磁共振成像定量评估节段性变应原挑战后的肺部炎症。
Am J Respir Crit Care Med. 2014 Mar 15;189(6):650-7. doi: 10.1164/rccm.201310-1825OC.
7
An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen.对屋尘螨或百慕大草过敏原致敏的猫的过敏性哮喘实验模型。
Int Arch Allergy Immunol. 2004 Oct;135(2):117-31. doi: 10.1159/000080654. Epub 2004 Sep 2.
8
Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.有或无哮喘的屋尘螨过敏患者鼻腔和皮肤中变应原诱导的迟发性炎症反应的比较。
Int Arch Allergy Immunol. 2003 Apr;130(4):266-74. doi: 10.1159/000070213.
9
Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.实验变应原免疫治疗方法:过敏性哮喘小鼠模型中的皮下和舌下脱敏。
Methods Mol Biol. 2021;2223:295-335. doi: 10.1007/978-1-0716-1001-5_20.
10
Allergen challenge in asthma: association of eosinophils and lymphocytes with interleukin-5.哮喘中的变应原激发试验:嗜酸性粒细胞和淋巴细胞与白细胞介素-5的关联
Allergy. 1995 Nov;50(11):891-8. doi: 10.1111/j.1398-9995.1995.tb02495.x.

引用本文的文献

1
Innate Immunity and Asthma Exacerbations: Insights From Human Models.先天性免疫与哮喘急性发作:来自人体模型的见解
Immunol Rev. 2025 Mar;330(1):e70016. doi: 10.1111/imr.70016.
2
Salience network resting state functional connectivity during airway inflammation in asthma: A feature of mental health resilience?哮喘气道炎症时突显网络静息态功能连接:心理健康复原力的特征?
Brain Behav Immun. 2024 Nov;122:9-17. doi: 10.1016/j.bbi.2024.07.042. Epub 2024 Aug 2.
3
Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.

本文引用的文献

1
Safety of investigative bronchoscopy in the Severe Asthma Research Program.在严重哮喘研究计划中进行研究性支气管镜检查的安全性。
J Allergy Clin Immunol. 2011 Aug;128(2):328-336.e3. doi: 10.1016/j.jaci.2011.02.042. Epub 2011 Apr 15.
2
Should we target allergen protease activity to decrease the burden of allergic airway inflammation?我们是否应该针对变应原蛋白酶活性来减轻过敏性气道炎症的负担?
Inflamm Allergy Drug Targets. 2008 Dec;7(4):288-95. doi: 10.2174/187152808786848379.
3
Repeated segmental allergen provocation: reassessment of provocation dose.
推进肺部免疫学研究:美国胸科学会官方研讨会报告。
Am J Respir Cell Mol Biol. 2022 Jul;67(1):e1-18. doi: 10.1165/rcmb.2022-0167ST.
4
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling.过敏性哮喘加重期气道纤维蛋白形成级联反应:对炎症和重塑的影响
Clin Proteomics. 2022 May 19;19(1):15. doi: 10.1186/s12014-022-09351-3.
5
Interleukin-1α Is a Critical Mediator of the Response of Human Bronchial Fibroblasts to Eosinophilic Inflammation.白细胞介素-1α 是人类支气管成纤维细胞对嗜酸性粒细胞炎症反应的关键介质。
Cells. 2021 Mar 2;10(3):528. doi: 10.3390/cells10030528.
6
Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.肺段过敏原激发后灌洗细胞上Siglec-8表达的特征分析。
Int Arch Allergy Immunol. 2018;177(1):16-28. doi: 10.1159/000488951. Epub 2018 Jun 7.
7
Eosinophil Activation Status in Separate Compartments and Association with Asthma.不同区室中嗜酸性粒细胞的活化状态及其与哮喘的关联
Front Med (Lausanne). 2017 Jun 12;4:75. doi: 10.3389/fmed.2017.00075. eCollection 2017.
8
Human airway eosinophils exhibit preferential reduction in STAT signaling capacity and increased CISH expression.人呼吸道中的嗜酸性粒细胞表现出 STAT 信号转导能力的优先降低和 CISH 表达的增加。
J Immunol. 2013 Sep 15;191(6):2900-6. doi: 10.4049/jimmunol.1300297. Epub 2013 Aug 16.
J Allergy Clin Immunol. 2009 Jan;123(1):270; author reply 270-1. doi: 10.1016/j.jaci.2008.10.016. Epub 2008 Dec 3.
4
Safety of segmental allergen challenge in human allergic asthma.人类过敏性哮喘中节段性变应原激发试验的安全性
J Allergy Clin Immunol. 2008 Mar;121(3):712-7. doi: 10.1016/j.jaci.2007.08.058. Epub 2007 Oct 29.
5
Investigative bronchoprovocation and bronchoscopy in airway diseases.气道疾病中的支气管激发试验及支气管镜检查
Am J Respir Crit Care Med. 2005 Oct 1;172(7):807-16. doi: 10.1164/rccm.200407-966WS. Epub 2005 Jul 14.
6
Protecting research subjects--the crisis at Johns Hopkins.保护研究对象——约翰·霍普金斯大学的危机
N Engl J Med. 2002 Feb 28;346(9):716-20. doi: 10.1056/NEJM200202283460924.
7
Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation.患有轻度和中度哮喘的受试者对节段性变应原激发的反应是相似的、可重复的、变应原特异性炎症。
J Allergy Clin Immunol. 2001 Dec;108(6):908-14. doi: 10.1067/mai.2001.119413.
8
Inhaled budesonide decreases airway inflammatory response to allergen.吸入布地奈德可降低气道对过敏原的炎症反应。
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):883-90. doi: 10.1164/ajrccm.162.3.9910077.
9
The effect of segmental bronchoprovocation with allergen on airway lymphocyte function.变应原节段性支气管激发对气道淋巴细胞功能的影响。
Am J Respir Crit Care Med. 1997 Nov;156(5):1421-8. doi: 10.1164/ajrccm.156.5.9703054.
10
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma.哮喘患者对节段性支气管肺激发试验的即刻和迟发性过敏反应。
Am J Respir Crit Care Med. 1997 May;155(5):1515-21. doi: 10.1164/ajrccm.155.5.9154851.